Volume 59, Issue 5 , Pages 772-780, November 2008
The impact of psoriasis on health care costs and patient work loss
To access this article, please choose from the options below
Supported by Novartis Pharmaceuticals Corp.
Disclosure: Dr Swensen, Dr Sung, Mr Doyle, and Dr Lobo are employees of and Dr Fowler, Dr Duh, Dr Rovba, Ms Buteau, Ms Pinheiro, Mr Mallett, and Dr Kosicki are consultants to Novartis Pharmaceuticals Corp.
Presented in part at the following poster sessions: 65th Annual Meeting of the American Academy of Dermatology, Washington, DC, February 2-6, 2007, and 12th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Arlington, VA, May 19-23, 2007.
PII: S0190-9622(08)01014-1
doi:10.1016/j.jaad.2008.06.043
© 2008 American Academy of Dermatology, Inc. Published by Elsevier Inc All rights reserved.
Volume 59, Issue 5 , Pages 772-780, November 2008
